Effective May 15, 2024, Andre van Zyl stepped down from his position as the Chief Technology Officer ("CTO") of Verde Resources, Inc
Departed
James Kellogg
Chief Financial Officer
Electronic Servitor Publication Network, Inc.
Effective
2024-05-14
Filed
May 17, 2024, 7:59 PM ET
On May 14, 2024, James Kellogg, the Chief Financial Officer (“CFO”) of the Company, provided a letter of resignation as CFO of the Company, effective as of May 14, 2024.
On May 11, 2024, Venk Nathamuni provided Cirrus Logic, Inc. (the “Company”) with notice of his intent to resign from his position as Chief Financial Officer effective May 24, 2024.
David Keffer, Corporate Vice President and Chief Financial Officer, will be retiring from the Company. Mr. Keffer will step down from his position on October 1, 2024, but will remain an employee of the Company until his retirement from the Company on February 21, 2025 to help facilitate an orderly transition.
Departed
Mark Caylor
Corporate Vice President and President, Mission Systems Sector
at the Effective Time, Terence Gallagher and Robert McNerney (the “Resigning Directors”) resigned as members of the Board.
Departed
Brian Gragnolati
Director
LAKELAND BANCORP INC
Effective
2024-05-15
Filed
May 16, 2024, 7:59 PM ET
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Lakeland’s directors and executive officers ceased serving as directors and executive officers of Lakeland.
Departed
Thomas J. Shara
Director
LAKELAND BANCORP INC
Effective
2024-05-15
Filed
May 16, 2024, 7:59 PM ET
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Lakeland’s directors and executive officers ceased serving as directors and executive officers of Lakeland.
Departed
Robert E. McCracken
Director
LAKELAND BANCORP INC
Effective
2024-05-15
Filed
May 16, 2024, 7:59 PM ET
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Lakeland’s directors and executive officers ceased serving as directors and executive officers of Lakeland.
Departed
James E. Hanson II
Director
LAKELAND BANCORP INC
Effective
2024-05-15
Filed
May 16, 2024, 7:59 PM ET
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Lakeland’s directors and executive officers ceased serving as directors and executive officers of Lakeland.
Departed
Brian M. Flynn
Director
LAKELAND BANCORP INC
Effective
2024-05-15
Filed
May 16, 2024, 7:59 PM ET
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Lakeland’s directors and executive officers ceased serving as directors and executive officers of Lakeland.
On May 14, 2024, John Park notified the Company of his intention to resign from the Board of the Company effective on and immediately prior to Mr. Murphy's appointment.
Joseph R. Martinetto notified The Charles Schwab Corporation (the “Company”) of his resignation from his position as Managing Director and Chief Operating Officer of the Company, effective as of June 28, 2024.
Peter B. Crawford notified the Company of his intent to retire from his Managing Director and Chief Financial Officer position at the Company following a planned transition period with the effective date of his retirement to be determined in the future.
Departed
Julie-Ann Signorille-Browne
Senior Executive Vice President and Chief Operating Officer
On May 10, 2024, Julie-Ann Signorille-Browne, Senior Executive Vice President and Chief Operating Officer of New York Community Bancorp, Inc. (“NYCB” or the “Company”), resigned from such role, effective as of May 24, 2024.
On May 11, 2024, Daniel Tempesta notified Cerence Inc. (the “Company”) of his decision to resign as Chief Financial Officer of the Company for personal reasons, effective as of May 17, 2024.
As previously reported in its Current Report on Form 8-K filed on November 6, 2023 (the “Previous Report”), Brian Regli gave written notice of his resignation (the “Resignation Letter”) from the board of directors (the “Board”) of the Company, and from the Audit Committee and Compensation Committee of the Board, effective May 16, 2024.
Departed
Leonardo Fernandes
Chief Financial Officer
Spectaire Holdings Inc.
Effective
2024-05-15
Filed
May 16, 2024, 7:59 PM ET
On May 15, 2024, Leonardo Fernandes, the Chief Financial Officer of Spectaire Holdings Inc. (the “Company”) tendered his resignation as the Company’s Chief Financial Officer, including any positions held with any of the Company’s subsidiaries, effective May 15, 2024.
On and effective May 10, 2024, James M. Strock resigned from the Board of Directors (the “Board”) of CVR Energy, Inc. (the “Company”).
Departed
Emmanuel Meyer
Director
Cactus Acquisition Corp. 1 Ltd
Filed
May 16, 2024, 7:59 PM ET
On May 16, 2024, each of Emmanuel Meyer, Huiyan Geng and Joseph C Thomassen, resigned as members of the Board of Directors, effective upon the closing of the Transfer.
Departed
Joseph C Thomassen
Director
Cactus Acquisition Corp. 1 Ltd
Filed
May 16, 2024, 7:59 PM ET
On May 16, 2024, each of Emmanuel Meyer, Huiyan Geng and Joseph C Thomassen, resigned as members of the Board of Directors, effective upon the closing of the Transfer.
Departed
Huiyan Geng
Director
Cactus Acquisition Corp. 1 Ltd
Filed
May 16, 2024, 7:59 PM ET
On May 16, 2024, each of Emmanuel Meyer, Huiyan Geng and Joseph C Thomassen, resigned as members of the Board of Directors, effective upon the closing of the Transfer.
On May 10, 2024, Mr. David LaPre notified the Board of Directors (the “Board”) of Calidi Biotherapeutics, Inc. (the “Company”) of his resignation as a director of the Company, including his position on each Board committee on which he served, effective immediately.
Departed
George E. Hansen III
Director
CROSSFIRST BANKSHARES, INC.
Effective
2024-05-14
Filed
May 16, 2024, 7:59 PM ET
George E. Hansen III retired from the Board of Directors (the "Board") of CrossFirst Bankshares, Inc. (the “Company”), effective immediately prior to the Company’s 2024 Annual Meeting of Shareholders held on May 14, 2024
Departed
Ayub Khattak
Director
Cue Health Inc.
Effective
2024-05-14
Filed
May 16, 2024, 7:59 PM ET
On May 12, 2024, Ayub Khattak provided notice of his resignation from the Board of Directors (the “Board”) of Cue Health Inc. ("the Company") and all committees thereof, to be effective as of May 14, 2024.
Departed
Rishi Reddy
Director
Cue Health Inc.
Effective
2024-05-15
Filed
May 16, 2024, 7:59 PM ET
On May 15, 2024, Rishi Reddy provided notice of his resignation from the Board and all committees thereof, effective immediately.
On May 16, 2024, AEON Biopharma, Inc. (“AEON” or the “Company”) terminated the Consulting Agreement (the “Agreement”) between AEON and Peter Reynolds, which has resulted in his termination as the Chief Financial Officer, principal financial officer and principal accounting officer of the Company effective as of May 17, 2024.
Effective May 15, 2024, Matthew Grove, a named executive officer who was previously responsible for the Lincoln National Corporation (“Company”) wealth management business and led the Company’s Life and Annuities businesses, ceased to be an executive officer of the Company.
Departed
Ronald A. Ballschmiede
Executive Vice President, Chief Financial Officer and Chief Accounting Officer
On February 12, 2024, Ronald A. Ballschmiede, Executive Vice President, Chief Financial Officer (“CFO”) and Chief Accounting Officer (“CAO”) and the Company’s principal financial officer and principal accounting officer of Sterling Infrastructure, Inc. (the “Company”), notified the Company of his plan to retire in 2024.
As a result of the Amendment, Mr. Ferrucci has provided the Company with notice of his intent to retire from his position as the Company’s Chief Operating Officer, effective on April 11, 2025.
On May 14, 2024, Briggs W. Morrison, M.D. advised the Board that he will resign from his position as a Class III member of our Board effective immediately.
On May 13, 2024, Kathy Mayerhofer, notified the Company of her decision to resign from her position as the Company’s Chief Sales Officer effective as of May 15, 2024 (the “Effective Date”).
Departed
Joseph Branch
director
MSD Investment Corp.
Effective
2024-05-10
Filed
May 15, 2024, 7:59 PM ET
On May 10, 2024, Joseph Branch notified the Board of Directors (the “ Board ”) of MSD Investment Corp. (the “ Company ”) that he was resigning as a director of the Board, effective immediately.
Departed
Stanislav Glezer
Executive Vice President, R&D and Chief Medical Officer
Dr. Glezer’s role as an officer and employee of the Company ended effective April 11, 2024
Departed
Joseph Garrett
Director
PACIFIC PREMIER BANCORP INC
Filed
May 15, 2024, 7:59 PM ET
Effective immediately prior to the Annual Meeting of Stockholders (the “2024 Annual Meeting”), Mr. Joseph Garrett retired from the Board of Directors (the “Board”) of Pacific Premier Bancorp, Inc. (the “Company”), including from his membership on the Board’s Compensation and Nominating and Governance Committees, and from the Board of Directors of Pacific Premier Bank (the “Bank Board”).
Departed
Florian Brand
Chief Executive Officer
ATAI Life Sciences N.V.
Effective
2024-12-31
Successor
Srinivas Rao
Filed
May 15, 2024, 7:59 PM ET
at which time he will be stepping down from his position as the Company's Chief Executive Officer
Departed
Tim Johnston
Director
Li-Cycle Holdings Corp.
Effective
2024-05-31
Filed
May 15, 2024, 7:59 PM ET
On May 8, 2024, Mr. Johnston notified the Chair of the Nominating and Governance Committee of the Board and the other Board members of his intention to resign as a director of the Company, following the conclusion of his employment with the Company on May 31, 2024
Jeff Sharritts, Cisco’s Executive Vice President and Chief Customer and Partner Officer, was informed that he would no longer remain in his role as Cisco’s Executive Vice President and Chief Customer and Partner Officer, effective May 15, 2024.
Departed
Indira Agarwal
Vice President, Controller and Chief Accounting Officer
On May 9, 2024, Indira Agarwal, Vice President, Controller and Chief Accounting Officer (principal accounting officer) of HF Sinclair Corporation (the “ Corporation ”), notified the Corporation that she is resigning from her role effective May 28, 2024 to pursue another opportunity.
On May 9, 2024, Matthew McClure notified Aligos Therapeutics, Inc. (the “Company”) of his resignation from his position as Chief Medical Officer of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.